These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 43345)

  • 1. Experimental otitis media in chinchillas following nasal colonization with type 7F Streptococcus pneumoniae: prevention after vaccination with pneumococcal capsular polysaccharide.
    Giebink GS; Berzins IK; Schiffman G; Quie PG
    J Infect Dis; 1979 Nov; 140(5):716-23. PubMed ID: 43345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal models for studying pneumococcal otitis media and pneumococcal vaccine efficacy.
    Giebink GS; Berzins IK; Quie PG
    Ann Otol Rhinol Laryngol Suppl; 1980; 89(3 Pt 2):339-43. PubMed ID: 6778342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of otitis media following vaccination with the capsular polysaccharide of Streptococcus pneumoniae in chinchillas.
    Giebink GS; Schiffman G; Petty K; Quie PG
    J Infect Dis; 1978 Oct; 138(4):480-7. PubMed ID: 30803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathogenesis of pneumococcal otitis media in chinchillas and the efficacy of vaccination in prophylaxis.
    Giebink GS
    Rev Infect Dis; 1981; 3(2):342-53. PubMed ID: 7256090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral immune response in chinchillas to the capsular polysaccharides of Streptococcus pneumoniae.
    Giebink GS; Schiffman G
    Infect Immun; 1983 Feb; 39(2):638-44. PubMed ID: 6832812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental otitis media due to Streptococcus pneumoniae: immunopathogenic response in the chinchilla.
    Giebink GS; Payne EE; Mills EL; Juhn SK; Quie PG
    J Infect Dis; 1976 Dec; 134(6):595-604. PubMed ID: 12236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Otitis media: the chinchilla model.
    Giebink GS
    Microb Drug Resist; 1999; 5(1):57-72. PubMed ID: 10332723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental otitis media in chinchillas.
    Lewis DM; Schram JL; Meadema SJ; Lim DJ
    Ann Otol Rhinol Laryngol Suppl; 1980; 89(3 Pt 2):344-50. PubMed ID: 6778344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of pneumococcal otitis media in chinchillas with human bacterial polysaccharide immune globulin.
    Shurin PA; Giebink GS; Wegman DL; Ambrosino D; Rholl J; Overman M; Bauer T; Siber GR
    J Clin Microbiol; 1988 Apr; 26(4):755-9. PubMed ID: 3366870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and efficacy of Streptococcus pneumoniae polysaccharide-protein conjugate vaccines against homologous and heterologous serotypes in the chinchilla otitis media model.
    Giebink GS; Meier JD; Quartey MK; Liebeler CL; Le CT
    J Infect Dis; 1996 Jan; 173(1):119-27. PubMed ID: 8537648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumococcal capsular polysaccharide-meningococcal outer membrane protein complex conjugate vaccines: immunogenicity and efficacy in experimental pneumococcal otitis media.
    Giebink GS; Koskela M; Vella PP; Harris M; Le CT
    J Infect Dis; 1993 Feb; 167(2):347-55. PubMed ID: 8421168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental otitis media after nasal inoculation of Streptococcus pneumoniae and influenza A virus in chinchillas.
    Giebink GS; Berzins IK; Marker SC; Schiffman G
    Infect Immun; 1980 Nov; 30(2):445-50. PubMed ID: 7439990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison otitis media due to types 3 and 23 Streptococcus pneumoniae in the Chinchilla model.
    Giebink GS; Quie PG
    J Infect Dis; 1977 Aug; 136 Suppl():S191-5. PubMed ID: 19539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can otitis media be prevented with pneumococcal vaccine?
    Mäkelä PH; Karma P
    Prog Clin Biol Res; 1980; 47():95-106. PubMed ID: 7010380
    [No Abstract]   [Full Text] [Related]  

  • 15. Pneumococcal vaccine and otitis media.
    Mäkelä PH; Sibakov M; Herva E; Henrichsen J; Luotonen J; Timonen M; Leinonen M; Koskela M; Pukander J; Pöntynen S; Grönroos P; Karma P
    Lancet; 1980 Sep; 2(8194):547-51. PubMed ID: 6106735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal vaccination of neonatal mice with polysaccharide conjugate vaccine for protection against pneumococcal otitis media.
    Sabirov A; Metzger DW
    Vaccine; 2006 Jul; 24(27-28):5584-92. PubMed ID: 16730398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumococcal vaccine and otitis media in infancy.
    Mäkelä PH; Karma P; Leinonen MK
    Bull Eur Physiopathol Respir; 1983; 19(2):235-8. PubMed ID: 6871501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of pneumococcal polysaccharide vaccine in preventing acute otitis media in infants in Huntsville, Alabama.
    Sloyer JL; Ploussard JH; Howie VM
    Rev Infect Dis; 1981; 3 Suppl():S119-23. PubMed ID: 7280444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumococcal otitis media following middle ear deflation.
    Meyerhoff WL; Giebink GS; Shea D
    Ann Otol Rhinol Laryngol; 1981; 90(1 Pt 1):72-6. PubMed ID: 7469300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of serum antibodies to pneumolysin with those to pneumococcal capsular polysaccharides in children with acute otitis media.
    Virolainen A; Jero J; Chattopadhyay P; Karma P; Eskola J; Leinonen M
    Pediatr Infect Dis J; 1996 Feb; 15(2):128-33. PubMed ID: 8822285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.